Literature DB >> 14668722

The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism.

Scott F Gallagher1, Daphne W Denham, Michel M Murr, James G Norman.   

Abstract

BACKGROUND: Minimally-invasive parathyroidectomy (MIP) appears to be changing preoperative treatment and referral patterns for sporadic, nonfamilial, non-multiple endocrine neoplasia, primary hyperparathyroidism (PHPT).
METHODS: The American Association of Clinical Endocrinologists membership was surveyed by mail (n=1406 members) regarding physician practices and surgical referral patterns for PHPT.
RESULTS: Seven hundred eighty-eight respondents (56%) practiced 17.0+/-0.4 years and referred 63%+/-1% of patients with PHPT for operation. Most endocrinologists (90%) used localizing studies before surgical referral (sestamibi, ultrasound scanning, technetium/thallium scanning, magnetic resonance imaging, computed tomography). Respondents identified symptoms, calcium homeostasis, bone density, health status, age, and general anesthesia risk as the most important considerations for surgical referral. Most respondents (79%) indicated that MIP availability would increase the number of patients who were referred for operation (P<.001), although most of the respondents stated that MIP would change the extent and duration of preoperative evaluations (P<.001). Respondents in practice for fewer years were more likely to refer patients for MIP (P<.001) and minimize preoperative evaluation (P<.05). Endocrinologists who had a patient with a complication after traditional parathyroidectomy were more likely to embrace MIP (P<.05).
CONCLUSIONS: MIP availability decreases the extent and duration of preoperative evaluation while decreasing the time from diagnosis to referral. MIP also lowers the endocrinologists' surgical referral threshold for PHPT, although it emphasizes the perceived shortcomings of traditional parathyroidectomy that are held by many physicians.

Entities:  

Mesh:

Year:  2003        PMID: 14668722     DOI: 10.1016/s0039-6060(03)00414-8

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Predictors of intra-operative parathyroid hormone decline in subjects operated for primary hyperparathyroidism by minimally invasive parathyroidectomy.

Authors:  M-H Gannagé-Yared; B Abboud; M Amm-Azar; A Saab; S Khalife; G Halaby; C Atallah; R Medlej; S Jambart
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

2.  Minimal invasive parathyroidectomy with local anesthesia for well-localized primary hyperparathyroidism: "Cerrahpasa experience".

Authors:  Serkan Teksoz; Yusuf Bukey; Murat Ozcan; Akif Enes Arikan; Safak Emre Erbabacan; Ates Ozyegin
Journal:  Updates Surg       Date:  2013-02-21

3.  Results from a national survey on the management of primary hyperparathyroidism.

Authors:  M Muñoz Torres; E Jodar Gimeno; R Reyes Garcia; G Martínez Diaz Guerra; J A Amado; S Gaztambide; J M Quesada Gómez
Journal:  J Endocrinol Invest       Date:  2011-12-15       Impact factor: 4.256

4.  National survey on the management of primary hyperparathyroidism by Swiss endocrinologists.

Authors:  T Clerici; R Warschkow; F Triponez; M Brändle
Journal:  Langenbecks Arch Surg       Date:  2007-02-09       Impact factor: 3.445

5.  Comparison of consumer information on the internet to the current evidence base for minimally invasive parathyroidectomy.

Authors:  Timothy McLean; Leigh Delbridge
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

6.  Cost-effectiveness of scan-directed parathyroidectomy.

Authors:  Radu Mihai; Mary Weisters; Michael J Stechman; Fergus Gleeson; Greg Sadler
Journal:  Langenbecks Arch Surg       Date:  2008-08-01       Impact factor: 3.445

7.  A decade of change in the uptake of parathyroidectomy in England and Wales.

Authors:  L M Evans; D Owens; D M Scott-Coombes; M J Stechman
Journal:  Ann R Coll Surg Engl       Date:  2014-07       Impact factor: 1.891

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.